National Institutes of Health
Federal agency · 821 grants in this directory · 721 currently open · page 1 of 17
The National Institutes of Health is a United States federal agency that administers research and development funding. It supports health and medical research across areas including oncology, infectious diseases, aging, cognitive health, autoimmune conditions, and complementary interventions, as well as the development of diagnostic and therapeutic devices. Applicants include educational institutions, nonprofits, small businesses, tribal governments, and individuals pursuing fellowships or workforce training opportunities.
Open grants (50)
- Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)Funding amount not specified · Closes October 30, 2026Closing soon
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional)Up to $2.2M · Closes October 30, 2026Closing soon
- HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)Funding amount not specified · Closes October 30, 2026Closing soon
- GREGoRi Innovation Projects (U01 Clinical Trial Optional)$3 – $500K · Closes October 30, 2026Closing soon
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Up to $1.2M · Closes October 30, 2026Closing soon
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)Funding amount not specified · Closes November 2, 2026Closing soon
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)Funding amount not specified · Closes November 2, 2026Closing soon
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)Funding amount not specified · Closes November 5, 2026Closing soon
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)Funding amount not specified · Closes November 6, 2026Closing soon
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)Up to $350K · Closes November 6, 2026Closing soon
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)Funding amount not specified · Closes November 9, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)Funding amount not specified · Closes November 9, 2026
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)Funding amount not specified · Closes November 10, 2026
- Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)$50K – $100K · Closes November 10, 2026
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)Funding amount not specified · Closes November 10, 2026
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)Up to $300K · Closes November 10, 2026
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)Funding amount not specified · Closes November 10, 2026
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)Funding amount not specified · Closes November 10, 2026
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)Up to $150K · Closes November 10, 2026
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)Funding amount not specified · Closes November 10, 2026
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)Up to $350K · Closes November 13, 2026
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)Up to $750K · Closes November 13, 2026
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)Up to $1M · Closes November 13, 2026
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)Funding amount not specified · Closes November 13, 2026
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)Up to $50K · Closes November 16, 2026
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)Up to $200K · Closes November 17, 2026
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)Funding amount not specified · Closes November 17, 2026
- NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)Up to $350K · Closes November 17, 2026
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)Funding amount not specified · Closes November 17, 2026
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)Funding amount not specified · Closes November 17, 2026
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)Funding amount not specified · Closes November 17, 2026
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)Funding amount not specified · Closes November 18, 2026
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)Funding amount not specified · Closes November 18, 2026
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)Funding amount not specified · Closes November 19, 2026
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)Funding amount not specified · Closes November 19, 2026
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)Funding amount not specified · Closes November 23, 2026
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)Up to $375K · Closes November 23, 2026
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)Funding amount not specified · Closes November 23, 2026
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)Funding amount not specified · Closes November 23, 2026
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)Funding amount not specified · Closes November 24, 2026
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)Funding amount not specified · Closes December 2, 2026
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)Funding amount not specified · Closes December 3, 2026
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)Funding amount not specified · Closes December 3, 2026
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)Funding amount not specified · Closes December 4, 2026
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)Up to $1.5M · Closes December 14, 2026
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)Up to $2M · Closes December 14, 2026
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)Up to $4M · Closes December 14, 2026
- Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)Up to $800K · Closes December 14, 2026
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)Up to $499K · Closes January 7, 2027
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)Funding amount not specified · Closes January 7, 2027
GrantRegister provides information, not advice. Eligibility requirements and deadlines are set by the funder and can change without notice. Confirm eligibility, deadlines, and requirements with National Institutes of Health before applying.